Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rebamipide for dual antiplatelet-induced gastrointestinal injury in coronary artery disease
TCTR20180104001Phase 3Recruiting
- Sponsor
- Thai Otsuka Pharmaceutical
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rebamipide in enteropathy, aspirin-induced enteropathy, sponsored by Thai Otsuka Pharmaceutical. Started Dec 2014; status: recruiting.
02
Drugs
rebamipide
03
Conditions
enteropathyaspirin-induced enteropathy
Beyond the preview
Go deeper on TCTR20180104001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180104001.